An official website of the United States government

Publication Information

PubMed ID
Public Release Type
Journal
Publication Year
2014
Affiliation
Authors
Austin J, Barbadora K, Bartosh SM, Bellah R, Bell L, Bhatnagar S, Brewer ED, Bukowski TP, Canning D, Carpenter MA, Cheng EY, Chesney RW, Chow JS, Clevenger S, DeBerardinis R, Decter R, DeFoor WR Jr, Denlinger J, Docimo SG, Drew W, Duby R, Falk T, Fathallah-Shaykh S, Fisher B, Fivush B, Fried AJ, Garrett B, Gerson AC, Greenfield SP, Green M, Haralam MA, Hickey R, Hoberman A, Iltis AS, Ivanova A, Jennings J, Kauffman JD, Keane V, Kearney D, Keren R, Klipner K, Kropp BP, Kuchler A, Lehman K, Lubianski T, Maier PS, Majd M, Mathews R, Mattoo TK, McLorie G, McMahon DR, Meyer S, Meyer T, Mirick A, Moxey-Mims M, Moyer SC, Nadkarni M, Nelson CP, Parker A, Peschansky L, Peters CA, Phillipi CA, Pohl HG, Powell L, Primack WA, Queen MA, Reed M, Renwick A, RIVUR Trial Investigators, Roecker EB, Rosoklija I, Rushton H Jr, Schwartz GJ, Shaikh N, Shaw K, Skoog SJ, Slaughenhoupt B, Sprague BM, Sutherland RW, Trachtman H, Tremont K, Triplett L, Wang MH, Waz W, Weems K, Wettengel KB, Youssefi R, Zaoutis L, Zaoutis T, Zerin MJ, Zhaung H, Ziessman HA
Studies
Citation
RIVUR Trial Investigators, Hoberman A, Greenfield SP, Mattoo TK, Keren R, Mathews R, Pohl HG, Kropp BP, Skoog SJ, Nelson CP, Moxey-Mims M, Chesney RW, Carpenter MA. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med 2014 Jun 19;370(25):2367-76. Epub 2014 May 4.

Abstract

Children with febrile urinary tract infection commonly have vesicoureteral reflux. Because trial results have been limited and inconsistent, the use of antimicrobial prophylaxis to prevent recurrences in children with reflux remains controversial.